These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 30158831)

  • 21. Aqueous-deficient dry eye disease: Preferred practice pattern guidelines on clinical approach, diagnosis, and management.
    Donthineni PR; Doctor MB; Shanbhag S; Kate A; Galor A; Djalilian AR; Singh S; Basu S
    Indian J Ophthalmol; 2023 Apr; 71(4):1332-1347. PubMed ID: 37026265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered ocular surface immune cell profile in patients with dry eye disease.
    Nair AP; D'Souza S; Shetty R; Ahuja P; Kundu G; Khamar P; Dadachanji Z; Paritekar P; Patel P; Dickman MM; Nuijts RM; Mohan RR; Ghosh A; Sethu S
    Ocul Surf; 2021 Jul; 21():96-106. PubMed ID: 33862224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigational drugs in dry eye disease.
    Nebbioso M; Fameli V; Gharbiya M; Sacchetti M; Zicari AM; Lambiase A
    Expert Opin Investig Drugs; 2016 Dec; 25(12):1437-1446. PubMed ID: 27754718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mouse models in studies on the etiology of evaporative dry eye disease.
    Widjaja-Adhi MAK; Chao K; Golczak M
    Exp Eye Res; 2022 Jun; 219():109072. PubMed ID: 35413281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preservation of tear film integrity and inhibition of corneal injury by dexamethasone in a rabbit model of lacrimal gland inflammation-induced dry eye.
    Nagelhout TJ; Gamache DA; Roberts L; Brady MT; Yanni JM
    J Ocul Pharmacol Ther; 2005 Apr; 21(2):139-48. PubMed ID: 15857280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TRI Microspheres prevent key signs of dry eye disease in a murine, inflammatory model.
    Ratay ML; Balmert SC; Acharya AP; Greene AC; Meyyappan T; Little SR
    Sci Rep; 2017 Dec; 7(1):17527. PubMed ID: 29235530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LFA-1/ICAM-1 Interaction as a Therapeutic Target in Dry Eye Disease.
    Pflugfelder SC; Stern M; Zhang S; Shojaei A
    J Ocul Pharmacol Ther; 2017; 33(1):5-12. PubMed ID: 27906544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Rabbit Model of Aqueous-Deficient Dry Eye Disease Induced by Concanavalin A Injection into the Lacrimal Glands: Application to Drug Efficacy Studies.
    Honkanen RA; Huang L; Rigas B
    J Vis Exp; 2020 Jan; (155):. PubMed ID: 32065120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age-related Defects in Ocular and Nasal Mucosal Immune System and the Immunopathology of Dry Eye Disease.
    Farid M; Agrawal A; Fremgen D; Tao J; Chuyi H; Nesburn AB; BenMohamed L
    Ocul Immunol Inflamm; 2016 Jun; 24(3):327-47. PubMed ID: 25535823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intricate insights into immune response in dry eye disease.
    Kaur RP; Gurnani B; Kaur K
    Indian J Ophthalmol; 2023 Apr; 71(4):1248-1255. PubMed ID: 37026255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [If Artificial Tears Aren't Enough. The Importance of Inflammatory Processes in Dry Eye Disease. Practical Aspects of an Anti-Inflammatory Therapy of Dry Eye Disease].
    Pleyer U; Geerling G; Schrader S; Jacobi C; Kimmich F; Messmer E
    Klin Monbl Augenheilkd; 2020 May; 237(5):655-668. PubMed ID: 32434249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dry eye as a mucosal autoimmune disease.
    Stern ME; Schaumburg CS; Pflugfelder SC
    Int Rev Immunol; 2013 Feb; 32(1):19-41. PubMed ID: 23360156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of symptoms experienced by persons with dry eye disease while driving in China.
    Wang Y; Lv H; Liu Y; Jiang X; Zhang M; Li X; Wang W
    Eye (Lond); 2017 Nov; 31(11):1550-1555. PubMed ID: 28622318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dry eye disease: pathophysiology, classification, and diagnosis.
    Perry HD
    Am J Manag Care; 2008 Apr; 14(3 Suppl):S79-87. PubMed ID: 18452371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternative therapies for dry eye disease.
    Mittal R; Patel S; Galor A
    Curr Opin Ophthalmol; 2021 Jul; 32(4):348-361. PubMed ID: 34010229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment of a Severe Dry Eye Model Using Complete Dacryoadenectomy in Rabbits.
    Honkanen RA; Huang L; Huang W; Rigas B
    J Vis Exp; 2020 Jan; (155):. PubMed ID: 31984964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of benign essential blepharospasm on dry eye disease and ocular inflammation.
    Lu R; Huang R; Li K; Zhang X; Yang H; Quan Y; Li Q
    Am J Ophthalmol; 2014 Mar; 157(3):591-7.e1-2. PubMed ID: 24269849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Classifying signs and symptoms of dry eye disease according to underlying mechanism via the Delphi method: the DIDACTIC study.
    Labetoulle M; Bourcier T; Doan S;
    Br J Ophthalmol; 2019 Oct; 103(10):1475-1480. PubMed ID: 30636211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Palate Lung Nasal Clone (PLUNC), a Novel Protein of the Tear Film: Three-Dimensional Structure, Immune Activation, and Involvement in Dry Eye Disease (DED).
    Schicht M; Rausch F; Beron M; Jacobi C; Garreis F; Hartjen N; Beileke S; Kruse F; Bräuer L; Paulsen F
    Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7312-23. PubMed ID: 26559477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular evidence for the role of inflammation in dry eye disease.
    Ganesalingam K; Ismail S; Sherwin T; Craig JP
    Clin Exp Optom; 2019 Sep; 102(5):446-454. PubMed ID: 30630216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.